These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 20881664)

  • 1. Intrapulmonary disposition of amphotericin B after aerosolized delivery of amphotericin B lipid complex (Abelcet; ABLC) in lung transplant recipients.
    Husain S; Capitano B; Corcoran T; Studer SM; Crespo M; Johnson B; Pilewski JM; Shutt K; Pakstis DL; Zhang S; Carey ME; Paterson DL; McCurry KR; Venkataramanan R
    Transplantation; 2010 Dec; 90(11):1215-9. PubMed ID: 20881664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation.
    Borro JM; Solé A; de la Torre M; Pastor A; Fernandez R; Saura A; Delgado M; Monte E; Gonzalez D
    Transplant Proc; 2008 Nov; 40(9):3090-3. PubMed ID: 19010204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nebulized liposomal amphotericin B prophylaxis for Aspergillus infection in lung transplantation: pharmacokinetics and safety.
    Monforte V; Ussetti P; López R; Gavaldà J; Bravo C; de Pablo A; Pou L; Pahissa A; Morell F; Román A
    J Heart Lung Transplant; 2009 Feb; 28(2):170-5. PubMed ID: 19201343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphotericin B disposition after aerosol inhalation in lung transplant recipients.
    Marra F; Partovi N; Wasan KM; Kwong EH; Ensom MH; Cassidy SM; Fradet G; Levy RD
    Ann Pharmacother; 2002 Jan; 36(1):46-51. PubMed ID: 11816256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled amphotericin B as fungal prophylaxis in heart transplant recipients.
    Wilde AM; Nailor MD
    Conn Med; 2011; 75(10):613-5. PubMed ID: 22216677
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study.
    Lowry CM; Marty FM; Vargas SO; Lee JT; Fiumara K; Deykin A; Baden LR
    Transpl Infect Dis; 2007 Jun; 9(2):121-5. PubMed ID: 17461997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-comparative evaluation of the safety of aerosolized amphotericin B lipid complex in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Alexander BD; Dodds Ashley ES; Addison RM; Alspaugh JA; Chao NJ; Perfect JR
    Transpl Infect Dis; 2006 Mar; 8(1):13-20. PubMed ID: 16623816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of invasive aspergillosis in lung transplant recipients by detection of galactomannan in the bronchoalveolar lavage fluid.
    Pasqualotto AC; Xavier MO; Sánchez LB; de Oliveira Costa CD; Schio SM; Camargo SM; Camargo JJ; Sukiennik TC; Severo LC
    Transplantation; 2010 Aug; 90(3):306-11. PubMed ID: 20548265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerosol deposition of lipid complex amphotericin-B (Abelcet) in lung transplant recipients.
    Corcoran TE; Venkataramanan R; Mihelc KM; Marcinkowski AL; Ou J; McCook BM; Weber L; Carey ME; Paterson DL; Pilewski JM; McCurry KR; Husain S
    Am J Transplant; 2006 Nov; 6(11):2765-73. PubMed ID: 17049064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylaxis with nebulized liposomal amphotericin B for Aspergillus infection in lung transplant patients does not cause changes in the lipid content of pulmonary surfactant.
    Monforte V; López-Sánchez A; Zurbano F; Ussetti P; Solé A; Casals C; Cifrian J; de Pablos A; Bravo C; Román A
    J Heart Lung Transplant; 2013 Mar; 32(3):313-9. PubMed ID: 23332731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive fungal infections in lung transplantation: role of aerosolised amphotericin B.
    Solé A
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S161-5. PubMed ID: 19013342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aerosolized liposomal Amphotericin B: a potential prophylaxis of invasive pulmonary aspergillosis in immunocompromised patients.
    Kamalaporn H; Leung K; Nagel M; Kittanakom S; Calvieri B; Reithmeier RA; Coates AL
    Pediatr Pulmonol; 2014 Jun; 49(6):574-80. PubMed ID: 23843366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphotericin B in lung transplant recipients.
    Klepser ME
    Ann Pharmacother; 2002 Jan; 36(1):167-9. PubMed ID: 11816247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of aerosolized amphotericin b formulations for prophylaxis trials among lung transplant recipients.
    Perfect JR; Dodds Ashley E; Drew R
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S207-10. PubMed ID: 15546119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility, tolerability, and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation.
    Monforte V; Ussetti P; Gavaldà J; Bravo C; Laporta R; Len O; García-Gallo CL; Tenorio L; Solé J; Román A
    J Heart Lung Transplant; 2010 May; 29(5):523-30. PubMed ID: 20061165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of aerosolized amphotericin B lipid complex in lung transplant recipients.
    Palmer SM; Drew RH; Whitehouse JD; Tapson VF; Davis RD; McConnell RR; Kanj SS; Perfect JR
    Transplantation; 2001 Aug; 72(3):545-8. PubMed ID: 11502995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary extraction and accumulation of lipid formulations of amphotericin B.
    Matot I; Pizov R
    Crit Care Med; 2000 Jul; 28(7):2528-32. PubMed ID: 10921589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic efficacy of single dose pulmonary administration of amphotericin B inhalation powder in a guinea pig model of invasive pulmonary aspergillosis.
    Kirkpatrick WR; Najvar LK; Vallor AC; Wiederhold NP; Bocanegra R; Pfeiffer J; Perkins K; Kugler AR; Sweeney TD; Patterson TF
    J Antimicrob Chemother; 2012 Apr; 67(4):970-6. PubMed ID: 22240402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micafungin versus amphotericin B lipid complex for the prevention of invasive fungal infections in high-risk liver transplant recipients.
    Sun HY; Cacciarelli TV; Singh N
    Transplantation; 2013 Sep; 96(6):573-8. PubMed ID: 23842191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between concentrations of amphotericin B in infected lung lesion and in uninfected lung tissue in a patient treated with liposomal amphotericin B (AmBisome).
    Watanabe A; Matsumoto K; Igari H; Uesato M; Yoshida S; Nakamura Y; Morita K; Shibuya K; Matsubara H; Yoshino I; Kamei K
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e220-3. PubMed ID: 19959388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.